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Conclusions: The knee cartilage of the Hartley guinea pig undergoes
an increase in the expression of genes associated with hypertrophy by
12 months of age coincident with the development of severe osteoarthritic
changes. Compared to the OA-prone Hartley strain, Strain 13 guinea pig
knee cartilage showed much lower expression of genes associated with
the hypertrophic cartilage phenotype. These ﬁndings are compatible with
the lesser severity of OA in this model. Interestingly, Hartley and Strain 13
guinea pigs showed similar and high ADAMTS-5 mRNA expression,
suggesting that ADAMTS-5 may be relevant in OA development in the
guinea pig model, but may not account for the differential susceptibility of
the two strains to OA.
65 FRIZZLED RELATED PROTEIN (FRZB) IS INVOLVED IN
DIFFERENT ASPECTS OF JOINT BIOLOGY AND PATHOLOGY
R.J. Lories, J. Peeters, F.P. Luyten. Katholieke Universiteit Leuven,
Leuven, BELGIUM
Purpose: The Frizzled related protein (FRZB) gene has been associ-
ated with susceptibility to osteoarthritis in different cohorts. FRZB is a
secreted antagonist of the WNT signaling pathway originally identiﬁed in
a chondrogenic extract of articular cartilage. We have generated Frzb−/−
mice and demonstrated that this loss of function model shows increased
cartilage damage in different induced mouse models of osteoarthritis.
Deletion of Frzb is associated with increased Wnt signaling and increased
matrix metalloproteinase activity and expression. In addition, cortical bone
thickness and adaptive bone formation upon loading are increased in
Frzb−/− mice as compared to wild-types. Here, we further evaluated the
spontaneous development of knee and hip osteoarthritis in a cohort of
normal aging mice as well as a cohort of mice exposed to voluntary
running activity. In addition we studied the effect of Frzb deletion on
enthesophyte/osteophyte formation in the spontaneous model of arthritis
in DBA/1 mice.
Methods: Aging Frzb−/− and wild-type mice were evaluated by X-rays
at week 26 and 52. In another cohort, Frzb−/− and wild-type mice were
grouped and a running wheel was introduced into the cage at the age of
7 weeks. At week 8, all mice were caged solitarily with a running wheel
available. Mice were allowed free exercise for 6 to 12 months and dis-
tances run were recorded daily. At the end of the experiment, mice were
sacriﬁced and joints were processed for histological evaluation. Cartilage
damage, synovitis and osteophyte formation were scored. Muscle ﬁber
composition of the soleus and extensor digitorum longus were studied
by immunoﬂuorescence. Frzb−/− mice were backcrossed onto the DBA/1
background for over 7 generations. Male DBA/1 mice from different litters
were caged together at the age of 10 weeks (>5 males per cages) and
observed for clinical signs of arthritis. Alternatively wildtype DBA/1 males
were treated with intramuscular injections of plasmid containing Frzb
under control of a CMV promoter every three weeks (week 11, 14, 17
and 20). At the end of these experiments (week 30 and 25 respectively),
mice were sacriﬁced and histological severity of disease was evaluated.
Results: No statistical differences in spontaneous incidence or severity
of osteoarthritis were seen between Frzb−/− mice and wild-type mice.
At the age of 6 months, both female and male wild-type mice showed
signiﬁcantly greater voluntary running activity than the Frzb−/− mice
(p< 0.05). At one year, the difference was still signiﬁcant for male mice,
but not for females. Running exercise did not signiﬁcantly affect severity
of osteoarthritis. Differences in distances run were not explained by
abnormalities in muscle composition.
In the spontaneous model of joint remodeling, average clinical disease
severity score and average clinical severity score per affect animal were
higher in wildtype as compared to Frzb−/− mice. Average histomor-
phological severity score was also higher in wild-type as compared to
Frzb−/− mice. In contrast, overexpression of Frzb by intramuscular plasmid
injection did not affect clinical incidence, severity and histomorphological
disease severity scores.
Conclusions: Absence of Frzb in mice does not lead to increased inci-
dence or severity of osteoarthritis. However, reduced voluntary physical
activity in running wheels suggests that absence of Frzb affects locomo-
toric function. The underlying mechanisms are not yet fully understood.
Deletion of Frzb also reduces endochondral bone formation in a mouse
model of ankylosis. These combined data further establish a role of FRZB
and WNT signaling in postnatal musculoskeletal biology and disease.
Functional polymorphisms in FRZB in humans may also affect osteophyte
formation and disease progression
66 ORAL CALCITONIN REDUCES CARTILAGE EROSION IN AN
OA RAT MODEL WITH BOTH TRAUMATIC INJURY AND
INCREASED SUBCHONDRAL BONE TURNOVER
R.H. Nielsen, B-C. Sondergaard, I. Byrjalsen, C. Christiansen,
M.A. Karsdal. Nordic Bioscience, Herlev, DENMARK
Purpose: Osteoarthritis (OA) is a disease that affects the entire artic-
ular joint, with both changes to the bone and cartilage compartments.
Increased bone turnover, as caused by oestrogen deﬁciency, has been
speculated to augment the severity of cartilage erosion and to accelerate
the pathogenesis of OA. An optimal intervention strategy for OA may
therefore ideally target both bone and cartilage mal metabolisms. Calci-
tonin has been shown to affect both osteoclasts and chondrocytes. We
investigated whether a novel oral formulation of salmon calcitonin could
reduce cartilage erosion and attenuate osteophyte formation, observed
secondary to induction of OA by combined partial medial meniscectomy
and ovariectomy of rats.
Methods: Four groups of 6 months old rats were subjected to sham,
ovariectomy (OVX) or a combined ovariectomy and partial medial menis-
cectomy (OVX+MNX) and administered twice daily with oral salmon
calcitonin (CT) (150mg/kg 5-CNAC + 2mg/kg calcitonin) or vehicle control
(V) (150mg/kg 5-CNAC) in the following way: (1) Sham+V; (2) OVX+V;
(3) OVX+MNX+V; (4) OVX+MNX+CT. Serum samples were collected at
baseline and 3, 6 and 8 weeks after surgery, and weights were recorded
at regular intervals. Animals were sacriﬁced 8 weeks after surgery, and
the tibia was processed for histology. C-terminal telopeptide of type II
collagen (CTX-II) was measured in the serum. Histological sections were
stained with Fast Green/Safranin O. The tibial plateau was equally divided
into a medial, central and lateral compartment, subsequently analysed
separately where the area of articular cartilage was measured using
automatic delineations in ImagePro. Areas of osteophytes situated in the
lateral compartment were scored separately.
Results:OVX surgery increased serum CTX-II levels by 260%, 240% and
53% in week 3, 6 and 8 after surgery, respectively. Meniscectomy did not
further increase the systemic CTX-II levels. Treatment with oral calcitonin
signiﬁcantly (p< 0.05) reduced CTX-II concentrations to below sham
levels. Ovariectomy alone resulted in a moderate cartilage loss of 5.8%
in the central tibial compartment compared to sham animals, whereas
OVX+MNX+V caused a heavy 33.3% (p< 0.05) cartilage loss. Treatment
with oral calcitonin reduced that cartilage loss by 52% (p=0.06). The
area of laterally occurring osteophytes increased 15-fold (p< 0.01) from
OVX+V to OVX+MNX+V animals. The effects of oral calcitonin reduced
the area of osteophytes by 55% when comparing the group OVX+MNX+V
to OVX+MNX+CT.
Conclusions: Currently there are no treatments available for OA. These
data are the ﬁrst to demonstrate that an oral formulation of calcitonin
protects against cartilage erosion and osteophyte formation in an in vivo
OA model with both traumatic injury and increased subchondral bone
turnover. The chondroprotective effects of salmon calcitonin may be a
combination of direct effect on chondrocytes in addition to the well-
established effect on bone resorption. Further clinical studies are needed
to validate the herein documented effects on cartilage erosion.
67 DELETION OF ESTROGEN RECEPTORS INDUCES
OSTEOPHYTES BUT DOES NOT PROMOTE EARLY
CARTILAGE DAMAGE IN MICE
Y.H. Sniekers1, G.J. van Osch1, A.G. Ederveen2, J. Inzunza3,
J.A. Gustafsson3, J.P. van Leeuwen1, H. Weinans1. 1Erasmus Medical
Center, Rotterdam, NETHERLANDS, 2Organon, Oss, NETHERLANDS,
3Karolinska Institutet, Huddinge, SWEDEN
Purpose: Since the prevalence of osteoarthritis OA is much higher in
postmenopausal than in premenopausal women, and cartilage damage
is increased after ovariectomy in several animal models, it is believed
that estrogen depletion plays a role in the onset or progression of OA.
Estrogen acts via the estrogen receptors (ERs) a and b. It is known
that deletion of ERs leads to changes in the metaphyseal bone. We
hypothesize that deletion of one or both estrogen receptors in female
mice will promote osteoarthritic changes in the cartilage and subchondral
bone.
Our aim was to study cartilage and subchondral bone changes
in knee joints of female ERalpha−/−, ERbeta−/−, and double
ERalpha−/−ERbeta−/− mice.
Methods: Tibias of 6-month-old female ERalpha−/−, ERbeta−/−, and
ERalpha−/−ERbeta−/− mice and their wildtype (wt, C57Bl/6 background)
littermates (n6 per group) were analyzed with microCT and histology.
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Using microCT (Skyscan, Belgium), trabecular bone volume fraction
(BV/TV), trabecular thickness (TbTh) and subchondral plate thickness
(PlTh) were calculated for the epiphyseal part of the tibias. Next, the
tibias were sectioned for histological analysis. The osteoarthritis cartilage
histopathology scoring was used to evaluate the cartilage damage in
medial and lateral compartment of the tibial epiphysis. For each compart-
ment, a maximum score of 24 can be reached. In addition, the presence
or absence of osteophytes was scored.
Results: Cartilage and osteophytes: Overall, the cartilage damage
scores were fairly low, up to a score of 4. In −/−, ERbeta−/−, and
ERalpha−/−ERbeta−/− mice, there was no difference in cartilage damage
score when compared to wt mice.
In the ERalpha−/−ERbeta−/− mice, more and/or larger (seen in more
histological sections) osteophytes were present compared with wt mice.
Subchondral plate thickness: In the ERalpha−/− and ERbeta−/− mice, no
difference in subchondral plate thickness was observed when compared
with wt mice. In the ERalpha−/−ERbeta−/− mice, the subchondral plate
was thinner than in the wt mice, but only at the lateral side.
Epiphysis: In the WT and ERalpha−/− mice, no signiﬁcant differences
were observed in trabecular BV/TV and TbTh. In contrast, in the
ERbeta−/− mice, trabecular BV/TV was 13% higher than in the wt, but
there was no difference in TbTh. In the ERalpha−/−ERbeta−/− mice,
trabecular BV/TV and TbTh were 11% lower than in the WT mice.
Conclusions: No cartilage changes were found in the ERalpha,
ERbeta−/−, ERalpha−/−ERbeta−/− mice at 6 months of age. In the single
knockout mice, deletion of one of the estrogen receptors may be compen-
sated by the other estrogen receptor. However, in the double knockout
mice, this is not the case. Increased cartilage damage was expected
in the double knockout mice, as osteoarthritic cartilage changes were
found in both rats and monkeys when estrogen signaling was inhibited by
ovariectomy. The differences in epiphyseal trabecular bone phenotype did
not inﬂuence the cartilage damage in the knockout mice. We did see more
or larger osteophytes in the double knockout mice, indicating that there
are some osteoarthritic developments. In the double knockout the lateral
subchondral plate thickness was decreased, which is also observed in
several osteoarthritic animal models. The increased osteophytosis and
changed subchondral plate is an indication that at later age these mice
likely develop more osteoarthritic changes.
68 AUTOLOGOUS PRGF IN THE OVINE ACL-TRANSECTED KNEE
OSTEOARTHRITIS MODEL
M. Sanchez1, E. Anitua2, J. Guadilla1, R. Prado2, J. Azofra1, N. Fiz1,
I. Andia2. 1Unidad de Cirugı´a Artrosco´pica, UCA, Vitoria, SPAIN,
2Biotechnology Institute, BTI IMASD, Min˜ano (Alava), SPAIN
Purpose: We assessed the capacity of PRGF to impact OA progres-
sion in sheep following trauma to the joint caused by ACL rejection
and cartilage defects performed on the medial condyle. This objective
was ﬁrst addressed by studying macroscopic cartilage changes in the
femoropatellar and femorotibial compartments.
Methods: Latxa sheep ranging in age from 3 to 8 years (5.0±1.9 years)
and weighing 62±9 kg (range: 47.8−74.4 kg) were used. A body condition
score was evaluated by a senior veterinarian by estimating the level of
muscling and fat [Editor1]deposition over and around the vertebrae in
the loin region (scored from 1 to 5). The Neiker-Technalia Animal Care
and Use Committee approved all procedures used. TGF-b levels were
assessed in PRGF and synovial ﬂuids by ELISA.
Sheep operations were performed bilaterally. Spinal anaesthesia was
induced in the hind limbs with bupivacaine. A medial parapatellar incision
was made and the patella was reﬂected laterally in order to expose the
ACL, which was subsequently transected. Complete thickness cartilage
defects were performed in the medial femoral condyles of both knees.
Following the surgery, free movement was allowed.
Ultrasound-guided inﬁltrations were initiated three weeks after ACL tran-
section. Sheep were treated with a series of six biweekly intra-articular
injections of 4ml of PRGF preparation and 4ml of saline in the contralat-
eral knee. PRGF and saline treatments were randomized to either the
right or the left knee.
OA induction was followed-up by radiography. Sheep were sacriﬁced
when OA features were evident on radiological images. This occurred at
36−38 weeks post-surgery, 16−18 weeks after the end of the treatment.
Knees were macroscopically studied for the presence of osteophytes
and signs of cartilage degeneration. Lateral and medial femur condyles,
tibial plateaux, and retropatellar cartilage were inspected. The articular
surfaces of the patella and tibial plateau were stained with diluted India
ink (1:5 v/v) to enhance detection of ﬁbrillation. Specimens were pho-
tographed, and images were assessed using a digital program. The ﬁbril-
lation area relative to the total area was calculated. ANOVA analysis was
performed to assess the inﬂuence of treatment modality on macroscopic
assessments. Age and body condition score were used as covariables.
Results: Body condition scoring ranged from 2.25 to 3.0 (2.73±0.27).
Most sheep (n = 9) were able to stand up 1−3 hours after surgery. PRGF
is a plasma preparation containing a moderate number of platelets,
448×106±194×106 platelets/cc, platelet volume was 4.8±0.3 ftl. The
levels of TGF-b1 in the PRGF were 13,240±5,650 ng/ml as assessed
by ELISA. Platelet number correlated signiﬁcantly with TGF-b1, Pearson
correlation = 0.9079, p< 0.001. Intra-articular TGF-b at the time of sacri-
ﬁce was 1983 pg/ml (CI: 1561–2406) in the treated joint and 1513 pg/ml
(CI: 1127–1898) in the saline group, p = 0.1015. Body condition score,
but not age, signiﬁcantly inﬂuenced the intra-articular levels of TGF-b1,
p = 0.0306. Transection of the ACL and full thickness defects in the medial
condyle resulted in the development of lesions in the lateral femoral
condyle, meniscus, tibial plateau, and patella. Osteophytes were located
mainly on the patellar trochlea ridge. Changes in the tibial plateau are
shown in Table 1. The percentage of patella ﬁbrillation was 10.1% (CI:
5.95%-14.24%) for the saline group and 4.3% (0.17%-8. 46%) for the
PRGF group, p = 0.053. Age signiﬁcantly inﬂuenced patella ﬁbrillation,
p = 0.036.
Conclusions: This study suggests that there may be a therapeutic beneﬁt
associated with intra-articular injection of PRGF following traumatic injury
to the knee.
69 DOES LITOVET, A HERBAL REMEDY MADE FROM ROSA
CANINA, ACT AS AN ANTI-INFLAMMATORY AGENT IN
HORSES EXPOSED TO STRENUOUS EXERCISE – A
RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL,
DOUBLE-BLINDED STUDY ON THE IMMUNE SYSTEM OF
HORSES, THEIR WORKING CAPACITY AND BEHAVIOUR
K. Winther1, J. Falk-Rønne2, A. Kharazmi3, A.V. Hansen1,
E.W. Hansen1. 1Frederiksberg Hospital, University of Copenhagen,
Frederiksberg, Copenhagen, DENMARK, 2The Horseclinic at Lunden,
Charlottenlund, Copenhagen, DENMARK, 3Department of Clinical
Microbiology, Rigshospitalet, University of Copenhagen, Copenhagen,
DENMARK
Purpose: A standardised powder prepared from rose-hip (Rosa canina),
has shown anti-inﬂammatory properties and improved the ﬂexibility of
the hip and knee joints and reduced pain in humans suffering from the
early as well as the late stages of osteoarthritis. Recently a galactolipid
named GOPO with anti-inﬂammatory properties was isolated from this
rose-hip powder. The present study aimed to investigate if LitoVet, a rose-
hip powder produced by HybenVital, especially for animals, would affect
the immune system, working capacity and behaviour of horses exposed
to strenuous exercise.
Methods: Seventy-four horses, all trotters, which often develop os-
teoarthritis early in their life, due to their intensive training program and
their performance in an oval track, were included in a double blind,
placebo controlled trial. The horses were randomized in blocks of three
of which two were given LitoVet (210 g daily as a dry powder added to
their food) and one was given the same amount of placebo powder with a
similar taste, odour and colour. Both groups of horses were then treated
for a three months period. The anti-inﬂammatory capacity was estimated
as chemotaxis of peripheral blood neutrophils using a Boyden chamber,
the anti-oxidative capacity by using chemiluminescence and by simply
measuring the vitamin C content of serum. The working capacity of the
horses was estimated by counting the seconds used to run 1000 meter
and the behaviour of the horses was evaluated on questionnaires which
was answered by the staff daily taking care of the horses (data given are
mean±sd).
Results: During LitoVet treatment neutrophil chemotaxis declined from
30.4±14.0 to 9.0±13.5 indicating an enhanced anti-inﬂammatory activity
(p< 0.004). No change was observed during placebo. LitoVet also signif-
icantly improved the antioxidant capacity when estimated as chemilumi-
nescence (p< 0.05) and the vitamin C content or serum (p< 0.05). Horses
on LitoVet also shortened their time to run 1000 meter as shown by a
mean decline of 1.1±1.5 second (p< 0.02). The placebo group slightly
increased their time to run the same distance. In agreement with the
changes described above it was reported from questionnaires, that the
horses beneﬁt from LitoVet treatment (p< 0.05) and that horses on LitoVet
were more lithe after strenuous exercise than horses treated with placebo
(p< 0.05).
